8:00 AM - 10:00 AM Friday, January 18

Plenary Session I - Paradigm Shifts in Neuromodulation: Beyond Programming and Frequency

This session will discuss advances in the field of neuromodulation and their role in improving patient outcomes. Topics covered will include the role of SCS trials and their predictive values on outcomes and the role of parathesias in pain control. In addition, advances in closed-loop stimulation will be discussed.

Read more...
Venue:
Caesars Palace
Speaker:

David A. Provenzano, MD

Julie G. Pilitsis, MD PHD

10:30 AM - 12:00 PM Friday, January 18

Plenary Session II - Targeted by Neuromodulation the Sequelae of Brain Injury

Brain injury has numerous sequelae, including disorders of consciousness, impairments in memory, post-traumatic stress, and other psychological changes. These changes have significant impact not only on the individual, but also on society. Numerous advances have been made in several areas to treat the effects of brain injury, using both invasive and non-invasive stimulation. In this session, we will survey the different modalities (electrical and ultrasound) used to treat the effects of brain injury, including both clinical evidence and the scientific theories underlying and motivating these approaches.

Read more...
Venue:
Caesars Palace
Speaker:

Peter Konrad, MD PhD

Nader Pouratian, MD PhD

10:30 AM - 12:00 PM Saturday, January 19

Plenary Session IV - The Opioid Epidemic and Neuromodulation: Understanding its Role in Treatment

The opioid crisis in the United States has brought about the rapid need for understanding the optimal role and the advancement of non-opioid forms of pain control. This session will highlight the current challenges surrounding opioids and the role that neuromodulation and innovative technologies may have in providing successful treatment strategies.

Read more...
Venue:
Caesars Palace
Speaker:

Stephanie G. Vanterpool, MD, MBA

David A. Provenzano, MD

Subscribe to this RSS feed

Faculty subject to change.